MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 72 filers reported holding MAGENTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $91,164 | +25.5% | 120,269 | +31.6% | 0.00% | – |
Q1 2023 | $72,614 | -1.2% | 91,373 | -50.9% | 0.00% | – |
Q4 2022 | $73,519 | -60.3% | 186,125 | +42.0% | 0.00% | -100.0% |
Q3 2022 | $185,000 | -23.6% | 131,059 | -35.0% | 0.00% | 0.0% |
Q2 2022 | $242,000 | -47.2% | 201,568 | +27.7% | 0.00% | 0.0% |
Q1 2022 | $458,000 | -34.5% | 157,819 | -0.0% | 0.00% | 0.0% |
Q4 2021 | $699,000 | -32.5% | 157,837 | +10.9% | 0.00% | -50.0% |
Q3 2021 | $1,036,000 | -38.1% | 142,365 | -16.8% | 0.00% | -50.0% |
Q2 2021 | $1,673,000 | -10.7% | 171,057 | +8.1% | 0.00% | -20.0% |
Q1 2021 | $1,874,000 | +20.4% | 158,292 | -20.2% | 0.01% | +25.0% |
Q4 2020 | $1,556,000 | +22.2% | 198,482 | +6.0% | 0.00% | -20.0% |
Q3 2020 | $1,273,000 | +1363.2% | 187,163 | +1513.5% | 0.01% | – |
Q2 2020 | $87,000 | -19.4% | 11,600 | -32.3% | 0.00% | -100.0% |
Q1 2020 | $108,000 | +3.8% | 17,130 | -6.5% | 0.00% | – |
Q4 2018 | $104,000 | – | 18,324 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |